Cleared Special

K150942 - Contour Next USB Blood Glucose Monitoring System

K150942 is an FDA 510(k) clearance for Contour Next USB Blood Glucose Monitori..., manufactured by Bayer Healthcare. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 231-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
231d
Days
Class 2
Risk

K150942 is an FDA 510(k) clearance for the Contour Next USB Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Bayer Healthcare (Mishawaka, US). The FDA issued a Cleared decision on November 25, 2015 after a review of 231 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Bayer Healthcare devices

FDA 510(k) Submission Details - K150942

510(k) Number K150942 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2015
Decision Date November 25, 2015
Days to Decision 231 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 88d · This submission: 231d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 420
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K150942.
OneTouch Ultra Plus Flex Blood Glucose Monitoring System
K151611 · Lifescan Europe · Dec 2015
iHealth Align Gluco-Monitoring System, iHealth BG5 wireless Smart Gluco-Monitoring System, iHealth BG5L wireless Smart Gluco-Monitoring System
K150833 · Andon Health Co, Ltd. · Dec 2015
Gmate Origin Blood Glucose Monitoring System
K151658 · Philosys, Inc. · Dec 2015
SD GlucoNFC Blood Glucose Monitoring System, SD GlucoNFC Multi Blood Glucose Monitoring System
K151265 · Sd Biosensor · Nov 2015
Gmate SMART Blood Glucose Monitoring System
K150299 · Philosys, Inc. · Nov 2015
Autosure Voice II Blood Glucose Monitoring System, Autosure Voice II Pro Blood Glucose Monitoring System, Autosure Blood Glucose Test Strips, Autosure Pro Blood Glucose Test Strips
K150396 · Apex BioTechnology Corp. · Oct 2015